MARKET

ORMP

ORMP

Oramed Pharmaceuticals Inc
NASDAQ
2.560
+0.030
+1.19%
Pre Market: 2.490 -0.07 -2.73% 05:10 07/17 EDT
OPEN
2.540
PREV CLOSE
2.530
HIGH
2.600
LOW
2.535
VOLUME
200
TURNOVER
0
52 WEEK HIGH
3.670
52 WEEK LOW
1.670
MARKET CAP
104.01M
P/E (TTM)
10.29
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at ORMP last week (0708-0712)?
Weekly Report · 2d ago
Weekly Report: what happened at ORMP last week (0701-0705)?
Weekly Report · 07/08 10:20
Weekly Report: what happened at ORMP last week (0624-0628)?
Weekly Report · 07/01 10:21
Oramed Pharmaceuticals authorizes share buyback program
Seeking Alpha · 06/26 13:15
ORAMED PHARMACEUTICALS: HTIT COMMITTING $70 MLN IN CASH, CO INVESTING $25 MLN IN CASH & STOCK IN JV
Reuters · 06/26 13:12
ORAMED PHARMACEUTICALS - AUTHORIZED COMMON STOCK REPURCHASE PLAN ALLOWING FOR BUY-BACK OF UP TO $20 MLN IN MAXIMUM VALUE OF ITS COMMON STOCK
Reuters · 06/26 13:00
ORAMED PHARMACEUTICALS INC. ANNOUNCES THE BUY-BACK OF ITS COMMON STOCK
Reuters · 06/26 13:00
Weekly Report: what happened at ORMP last week (0617-0621)?
Weekly Report · 06/24 10:25
More
About ORMP
Oramed Pharmaceuticals Inc. is a pharmaceutical company engaged in the research and development of pharmaceutical solutions with a technology platform. The Company has developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its Protein Oral Delivery (POD) technology is designed to protect drug integrity and increase absorption. Its pipeline includes ORMD-0801 (Oral Insulin) Diabetes, ORMD-0801 (Oral Insulin) NASH, and ORMD 0901 (Oral GLP-1). Its oral insulin (ORMD-0801) has the potential to create a new paradigm in the treatment of diabetes through oral delivery of insulin at an earlier stage of treatment. Its oral insulin capsule (ORMD-0801) has shown a reduction of liver fat content in early clinical trials. It is also developing an oral Glucagon-like peptide-1 (GLP-1) analog capsule (ORMD-0901), which is an incretin hormone that stimulates the secretion of insulin from the pancreas.

Webull offers Oramed Pharmaceuticals, Inc. stock information, including NASDAQ: ORMP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ORMP stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ORMP stock methods without spending real money on the virtual paper trading platform.